2018-02-22
1
Jörn Schneede
of Analgesic MedicationsClinical Pharmacology
Läkemedelscentrum
Contents of this Lecture
Clinical Pharmacology of:• Paracetamol (Acetaminophen)• Non-steroidal anti-inflammatory drugs (NSAIDS) / COX-2
specific inhibitors• Opioids•Warning against codeine
• Analgesics in renal and hepatic failure• Pain in premature children
2018-02-22
2
Clinical Pharmacology includes
• Mechanism of Action • Absorption/Distribution/Metabolism/ Elimination (ADME)• Indication for use / dosage• Adverse effects• Any special precautions that should be taken
• Contraindications• Pregnancy and breast-feeding• Infants/elderly/disabled• Interactions• Health economics, cost-utility, cost-effectiveness
ParacetamolAcetaminophen
Non Steroidal Anti-inflammatory Drugs
2018-02-22
3
Paracetamol
Paracetamol • Paracetamol has been in use for more
than a century• It has both analgesic and antipyretic action• Still, the exact mechanism of its action is unclear:
• Prostaglandin-synthesis (POX)
• COX-2• COX-3 (in dogs)• Descending serotinergic
pathways• PG-E2 inhibition in CNS• Cannabinoid system• NO-inhibitor (spinal cord)
2018-02-22
4
Absorption / Elimination
• It is available as tablets (adults), suspension or syrup for children and suppositories
• On oral administration it is absorbed from the intestine (70%), stomach and colon (30%)
• The rate of absorption is rapid and depends on the dose
• The time taken to reach maximum plasma concentration (Tmax) is 15 - 30 minutes depends on the preparation (“Zapp”, “Novum”)
• Tmax is 2 - 3 hours with suppositories• Bioavailability ranges from 60-90%
Elimination (mainly renal in conjugated forms)• Paracetamol is metabolized in the liver, mainly phase II reactions• Only 2 - 5% is excreted unchanged in urine
Metabolism / Elimination
2018-02-22
5
Indications and dosages
• It is used as an analgesic drug for mild to moderate pain– E.g. tooth ache / teething pain in children, back pain, joint and
muscle pain, headache, dysmenorrhoea• Relief of fever in adults and children
Dosage• Adults – Up to 1g oral / rectal, every 6 hours
• 4 g should not be exceeded / day
• Children – Oral / rectal 20 mg / kg – every 6 hours• 125 mg/ kg should not be exceeded
Side effects
• Paracetamol is normally well tolerated and has only few side effects at therapeutic doses
• It has good haematological tolerability and does not alter haemostasis / platelet function
2018-02-22
6
Caution
• Since it is metabolized in the liver it must be used with caution / or omitted in the presence of liver impairment• Max. dose 3 g/d• Do not use for prolonged time
• In patients with renal impairment, the dose of paracetamol should be reduced
• Do not exceed 4g/day in adults and 125 mg/ kg in children
Adverse effectsHepatotoxicity with an overdose of paracetamol
• This can occur when a patient does not get adequate relief with paracetamol and decides to take more than the prescribed dose of a maximum of 4g/day
• Or uses OTC-paracetamol in addition to Citodon
• Intentional overdose is the leading cause of acute liver failure in the US, UK and Australia
2018-02-22
7
Adverse Effects
• N-acetylcysteine (NAC) is the antidote for paracetamol poisoning and it is most effective when administered within 8 - 10 hours after ingestion
• Renal toxicity • Overdose can cause severe
kidney necrosis
Metabolism of acetaminophen (top center) to hepatotoxic metabolites. (GSH, glutathione; SG, glutathione moiety).
15
2018-02-22
8
Ändring av 200 µg/ml gränsen i 1976
Avvikelsesrapport
• Underläkare medicin, Skellefteå kontaktar mig som kemlab-jour. • Under perioden 16 09 14 – 16 09 21 har vi rapporterat svängande S-
paracetamol mellan 9 och 22 µmol/L i prov från denna patient. • Acetylcysteinbehandling inneliggande under denna tid på grund av
påvisbart S-paracetamol. • Underläkaren uppfattar att patienten är leversjuk. • Enligt giftinformationscentralens anvisning ska
acetylcysteinbehandling pågå tills att S-paracetamol ej längre kan påvisas.
• Underläkaren har varit i kontakt med giftinformationscentralen som ställt sig frågande till de svängande S-paracetamolkoncentrationerna
17
2018-02-22
9
18
Bilirubin interferes – ultrafiltration of sample
Adverse Effects
2018-02-22
10
Paracetamol and ASD
2018-02-22
11
Review and metaanalysis
Relatively vague concepts
2018-02-22
12
It is not decided yet
NSAIDsNon Steroidal Anti-inflammatory Drugs
2018-02-22
13
History of Aspirin
• Salicylate from the bark of the willow tree and was used to treat fever and rheumatism for centuries
• In the late 19th century, salicylic acid and later acetylsalicylic acid was synthesized and called aspirin.
• Aspirin was widely used to treat fever, pain, cardiovascular disease
• Reye syndrome in children after viral infection• Replaced by paracetamol in the 80s
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
• They are diverse group of compounds which were later synthesized, with actions similar to that of aspirin and became known as NSAIDs
• The mechanism of action of aspirin / NSAIDs (COX-inhibition) was discovered in the 1960’s by Prof Vane, who was awarded a Nobel prize in Medicine in 1982
2018-02-22
14
Non-steroidal Anti-inflammatory Drugs -NSAIDs
• NSAIDs are widely used to treat pain and inflammation
• They act through inhibition of the two isoforms of the enzyme cyclooxygenase (COX) – i.e. COX-1 and COX-2
• NSAIDs that act on both the enzymes are known as non-selective NSAIDs (ns-NSAIDs)
• NSAIDs which act predominantly on the COX-2 enzyme are known as specific COX-2 inhibitors (also referred to as Coxibs)
The Two Isoforms of COX
• COX-1 is a normal constituent in the body for homeostasis, such as in:• Gastric mucosa – gastric cytoprotection• Kidney – Sodium and water balance / renal perfusion• Platelets – for aggregation
• COX-2 is induced in the presence of injury, inflammation and neoplastic disease
• COX-2 is also a normal constituent in the many organs such as: Kidney, brain, endothelium, ovary and uterus
2018-02-22
15
What happens when there is tissue injury?
Membrane phospholipidsCell wallinjury
Releases
Arachidonic Acid
Phospholipase A2
COX-1 & COX-2 that is induced with injury and inflammation, cancer
PGH2 (Prostaglandin H2)
PGD2 TXA2PGE2PGI2 PGF2
Prostaglandins- PGE2 as the most significant Thromboxane
Phospholipid from cell membrane
Arachidonic Acid
PGH2 5-HPETE
Leukotrienes
LipoxygenaseCyclo-oxygenase
ProstaglandinsThromboxane
These inflammatory mediators activate the nociceptors on the Aδ and c fibres and result in pain and sensitization
Arachidonic Acid Cascade
2018-02-22
16
NSAIDs / COX-2 inhibitors
Reduced Prostaglandins and Thromboxane, resulting in reduced pain
Phospholipid from cell membrane
Arachidonic Acid
PGH2 5-HPETE
Leukotrienes
LipoxygenaseCyclo-oxygenase
ProstaglandinsThromboxane
Arachidonic Acid Cascade
Increased risk of asthma
ns-NSAIDs
Acetylsalicylic acid (aspirin)• Tablet, suppository
Ibuprofen• Tablet, suspension for children
• Faster onset of action
• Inhibits platelet effects of ASA
Naproxen• Tablet
• Longer effect times
Diclofenac• Tablet, suppositories, parenteral forms
available
• Possibly highest CVD-risk among ns-NSAIDs
Celecoxib (Celebra)• Oral capsules
Etoricoxib (Arcoxia)• Tablets
Parecoxib (Dynastat) • Parenteral
COX-2 specific inhibitors (= Coxibs)
2018-02-22
17
Absorption and Elimination
• When administered orally, aspirin, ns-NSAIDs and Coxibs are well absorbed and reach therapeutic levels within 30 to 60 minutes.
Indications
• Both the ns-NSAIDs and Coxibs have the same efficacy in postoperative analgesia• Sole analgesia for day-surgery • Along with opioids for major surgery
• Musculo-skeletal pain – e.g. back pain, joints, muscle sprains etc.• Osteoarthritis• Rheumatoid arthritis
• Not indicated for neuropathic pain
2018-02-22
18
Side effects / Adverse effects
Gastrointestinal effects•The risk of erosions, ulcers and bleeding is higher with ns-NSAIDs compared to Coxibs.
•Risk is greater • In elderly patients• Those who are also taking aspirin
•Risk can be reduced by adding a proton-pump inhibitor (e.g. omeprazole) to ns-NSAIDs.
• H2 receptor blockers are not very effective.
Renal effects
• Both COX-1 & 2 are constituent enzymes in the kidney• Maintain renal perfusion and sodium/water balance
• Both ns-NSAIDs and Coxibs can cause• Hypertension, edema• Counteract anti-hypertensive treatment• Decrease GFR that may be significant in patients with
impaired renal function or transient hypotension / hypovolaemia in the postoperative period
2018-02-22
19
PG
↑PG
NSAIDS ↓PG
AII
↑AII
ACEi/ARB ↓AII
Normal
↓volume
↓volumewith ACEi + NSAID
Afferent Glomerulus Efferent
Cardiovascular effects
• Coxibs: large intervention studies for primary prophylaxis of CRC and Mb Alzheimer
• Some studies have shown that there was a higher risk of thrombotic cardiovascular events (stroke, heart attack) when on Coxibs when compared to ns-NSAIDs such as naproxen
• Other studies have shown that the cardiovascular events are similar, but possibly highest for etoricoxib and diclofenac
• Current recommendations are that Coxibs should not be used in patients with active cardiovascular disease and a known thrombotic condition
2018-02-22
20
Summary
• Both drugs are effective in providing pain relief for moderate pain
• The mechanism of action of both groups of drugs is by inhibiting the COX-2 enzyme that is induced with injury, inflammation and cancer
• Gastrointestinal side effects are less with coxibs
NS-NSAIDs / Coxibs
Summary (cont.)
• Coxibs have no effect on platelet aggregation• Both NS-NSAIDs / Coxibs should be used with caution in
patients with renal impairment and in the elderly• Coxibs should not be used in patients with active
cardiovascular disease or known thrombotic risks• Coxibs can be given to patients with aspirin
sensitive asthma• Both drugs should be used for the shortest period of time at
the lowest effective dosage
NS-NSAIDs / Coxibs
2018-02-22
21
Opioids
Opioids
• Opium alkaloids derived from the opium poppy has been used for pain relief for centuries
• Morphine was isolated by Sertuner in 1813• The glass syringe was introduced in 1844• Since then morphine has been the mainstay in the
management of severe pain• The term “opioid” is referred to any drug, either natural, semi-
synthetic or fully synthetic, which has actions similar to morphine
2018-02-22
22
Chemical structure
Available Opioids
• Opioids on the WHO essential drug list• Morphine• Codeine• Tramadol
Natural• Morphine• Codeine
Semi-Synthetic• Hydromorphone• Oxycodone• Diacetylmorphine
(heroin) • Naloxone
(antagonist)
Fully Synthetic• Pethidine
(meperidine)• Tramadol• Methadone• Fentanyl• Alfentanil• Sufentanil• Remifentanil
2018-02-22
23
Chemical structure
Opioids can be classified as:
• Strong opioids used for severe pain– Morphine, Oxycodone, Pethidine, Fentanyl
• Weak Opioids used for moderate pain– Codeine, Tramadol
Tapentadol
2018-02-22
24
Weak opioids
The analgesic ladder for acute pain management
Strong opioids
Mechanism of Action
• Opioids act by binding to opioid receptors (complex proteins embedded within the cell membrane of neurons)
Opioid receptors are found in the brain and in the dorsal horn of the spinal cord
There are three different opioid receptors - µ, δ, κ
µ - most relevant as all clinically used opioids exert their action via the µ -opioid receptor
2018-02-22
25
Opioid receptor types
Mechanism of Action
2018-02-22
26
Cellular Actions
• Opioids bind to opioid receptors • G-protein coupled receptors
• Closing voltage-gated Ca2+ channels on presynaptic nerve terminals• Inhibit release of• Glutamate, acetylcholine, norepinephrine,
serotonin, and substance P• Hyperpolarizing and thus inhibiting postsynaptic neurons
by opening K+ channels• Inhibition of pain signals/pain perception
Morphine (strong opioid)
• Is the most widely used opioid for the control of severe pain
• It can be given by all large number of different routes
• It is well absorbed when given orally and has a bioavailability of around 30-35%.
• High extraction drug – bioavailability increases dramatically in liver failure / shunting
2018-02-22
27
Oral morphine
Immediate release morphine (e.g. Morfin Meda)• Aqueous / liquid morphine (usually prepared
as 1-2 mg / ml) • Tablet morphine (10 mg)• Need to be given every four hours for continuous relief of
severe painSustained Release (SR) Morphine Tablets (e.g. Dolcontin)• Morphine is released slowly over 12 hours • 10 mg, 30 mg, 60 mg• These tablets are given twice a day
Parenteral morphine (10 mg / I ml ampoule)
Intramuscular / subcutaneous morphine• Onset of Analgesia 15 - 20 min • Peak action 45 - 90 min• Duration of action 4 hours
Intravenous route is chosen when rapid control of severe pain is desired.
2018-02-22
28
Metabolism
The principle pathway of metabolism is conjugation with glucuronic acid in hepatic and extra-hepatic (kidney) sites • Morphine-3 and morphine-6 glucuronides that are excreted
mainly by the kidneys• Morphine-6-glucuronide is biologically active and more potent
than morphine itself• Morphine should be used with caution in patients with hepatic
and renal impairment
Codeine phosphate – “Weak” opioid
• Oral tablet 15mg; 30 mg
• Is well absorbed and there is no first pass metabolism
in the liver
• Codeine is metabolized to morphine (CYP2D6); which accounts for
its analgesic effect
• 60 mg of codeine has an equi-analgesic effect compared with
650 mg aspirin
• Has an anti-tussive effect and is often used in cough mixtures
• Is widely used in fixed combination with paracetamol• Cause minimal sedation, nausea, vomiting and constipation
2018-02-22
29
Metabolic pathways of codeine biotransformationN Engl J Med 2004;351:2827-31
Metabolic pathways of codeine biotransformationN Engl J Med 2004;351:2827-31
2018-02-22
30
2006
2018-02-22
31
2012
2018-02-22
32
2013
FDAApril 20th 2017
2018-02-22
33
ACOG Practice Advisory on Codeine and Tramadol for Breastfeeding Women, April 2017
• 1) Consider prescribing an opioid analgesic other than codeine or tramadol.
• According to the American Academy of Pediatrics Committee on Drugs, butorphanol, morphine, or hydromorphone are preferred agents for breastfeeding mothers requiring narcotics for pain control. Morphine and hydromorphone can be dosed via oral or IV route.
• 2) If a codeine-containing medication is considered the preferred choice, the risks and benefits of this drug and the reasoning behind the FDA warning should be discussed with each family.
FDA January 2018 Labeling Changes
2018-02-22
34
Tramadol – Weak opioid
• This is also known as an “atypical opioid”• It has a dual mechanism of action:
• weak opioid receptor binding properties• Inhibits the re-uptake of serotonin and noradrenaline at the
descending inhibitory pathway• This may become a problem when discontinuing the drug
• It is available • Oral capsule (50 mg)• Injection – 50 mg / ml – in 2 ml ampoules
Tramadol
• It is well absorbed when given orally• Time to effect is around 30 minutes and can last
5 - 6 hours• Sedation is minimal• Can cause nausea, vomiting, dizziness• Abuse potential is low • Is used as a weak opioid, however as it has a dual mechanism
of action – its analgesic efficacy is superior to codeine –Maximum daily dose is 400 mg
• Not for treatment of chronic pain / neuropathic pain
2018-02-22
35
Metabolism
• Tramadol is metabolized by the liver (CYP2D6 as codeine) and excreted by the kidneys
• Tramadol has an active metabolite (O-desmethyltramadol) – that is also excreted by the kidney
• The daily dose should be reduced in the presence of chronic renal failure
• Usefulness in chronic pain is debated
Läkemedelsverkets senaste rekommendation
2018-02-22
36
Opioid related side effects
• On initiation of opioid therapy, patients frequently report acute side effects of sedation, dizziness, nausea and vomiting
• After a few days these symptoms subside except for constipation
• This is noted in patients with cancer pain• (Constipation prophylaxis is very important)
Opioids and Tolerance Patients can develop tolerance when opioids are used for an extended period • E.g. cancer pain; intensive care unitsTolerance is defined as reduction of the pharmacological effect of an opioid:• When the same dose produces a lesser effect• Increasing doses of drug are required to produce the same effect • The mechanisms of the development of tolerance are complexOpioid-induced hyperalgesia (OIH)• a phenomenon observed in patients treated with opioids, who paradoxically
demonstrate an increased sensitivity to painful stimuli. • associated with hyperalgesia, allodynia, or both• often different quality/location than the original pain• N-methyl-D-aspartate receptor activation may have a central role•
2018-02-22
37
Physical Dependence and Addiction
Physical dependence is a state of adaptation by the body with extended use of an opioid • It is manifested by withdrawal symptoms with abrupt cessation
of the opioid, rapid dose reduction or administration of an opioid antagonist
Addiction to opioids is drug seeking behavior where the person is looking for opioids for its euphoric action rather than pain relief alone
Analgesics in liver and renal disease
2018-02-22
38
NSAID och cirrhos
2018-02-2293
2018-02-22
39
Analgesics in hepatic and renal failureLiver disease/cirrhosis Renal failure
Paracetamol Up to 3 g GFR >10-20: normal dose
NSAID Avoid AvoidMorphine Use with caution AvoidCodeine Avoid Avoid or reduce doseTramadol Avoid Avoid in severe renal
failureOxycodone Use with caution Great caution in severe
renal failureBuprenorfin Can be used, but dose
adjustments necessaryOK. No dose-adjustment
for transdermal prep.Remifentanil Can be used OKFentanyl Can be used, but monitor OKMethadone Not adviced OK, red. dose GFR < 10
Acute pain relief in premature infants
2018-02-22
40
2018-02-22
41
Pain in premature• Vegetative reactions to pain already seen from post-
gestational week 22• Lower liver enzyme activity –• slower elimination of opioids• longer effect times
• BBB not fully developed – more CNS exposure to opioids• More risk of respiratory depression, bradycardia,
hypotension• Relative distribution of μ, δ and κ- receptors is not fully
developed• Relative to body weight higher doses needed for
anesthesia
2018-02-22
42
Pain in premature (cont.)• Differential development of opioid receptors in time in
different areas of the pain system• Faster development of receptors in pons and medulla
oblongata region• Increased risk of respiratory depression,
bradycardia and rigidity• Despite all theses factors:• Opioids are useful as analgesics in premature children• Dose adjustments should primarily be based on
clinical effects and not mainly on adjustments according to body weight